News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
04
2023
-
12
Hand in hand to create a better future | Linuo Pharmaceutical and Linheng Pharmaceutical signed a strategic cooperation agreement!
Classification：
News
Corporate News
On December 3,Shandong Linuo Pharmaceutical Co., Ltd(hereinafter referred to as lino pharmaceutical) andHainan Linheng Pharmaceutical Co., Ltd.(hereinafter referred to as Lin Heng Pharmaceutical)Signing of strategic cooperation agreement. Chairman of Keyuan Pharmaceuticals and President of Liino PharmaceuticalsJiang HongshengLin Yuren, chairman of Lin Heng Pharmaceutical, led the company team to participate in the cooperation negotiation and signing ceremony.
Rino Pharmaceuticals is a modern, high-tech company focusing on the development, production and sales of chronic disease drugs.Digital Intelligence Pharmaceutical Enterprise, focusing on the preparation business, isA wholly-owned subsidiary of Shandong Keyuan Pharmaceutical Co., Ltd. (stock code 301281.SZ)The momentum of development has been strong in recent years. The company is committed to using digital medicine to protect life and health,Escort for the high quality of life of patients.
Lin Heng Pharmaceutical is a pharmaceutical company with a high influence in Hainan, with rich R & D experience and technical strength to produce"Conscience medicine, reassurance medicine, green medicineFor its mission, it produces in strict accordance with GMP standards, attaches importance to innovation-driven development, and focuses on providing high quality pharmaceutical products for patients.
Both sidesThe professional field is highly compatible, and the corporate culture values are similar.Based on the principle of complementary advantages, mutual benefit and win-win cooperation agreement, fullyRealNow resources integration, coordinated developmentContinuously enhance the technical strength and market competitiveness of enterprises.
The signing of this cooperation will bring great development opportunities for Linuo Pharmaceutical and Linheng Pharmaceutical.The two sides will carry out in-depth cooperation in many fields, complement each other's advantages and work together,Jointly promote the innovation and development of the pharmaceutical industryContinue to make positive contributions to the people's health.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China